Eizo’s high-rez monitor approved for breast tomo

The FDA has cleared Eizo’s 5-megapixel monochrome monitor for breast tomosynthesis, the Japanese company has announced.

Called the RadiForce GX540, the 2048 x 2560 monitor offers a contrast ratio of 1200:1, with deeper black levels than previous models for sharper reproductions of fine image details, according to Eizo. 

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease. 

CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.

The new technology shows early potential to make a significant impact on imaging workflows and patient care.